FKHR is a member of the FOXO subfamily of Forkhead transcription factors, which are important targets for insulin and growth factor signaling. FKHR contains three predicted protein kinase B phosphorylation sites (Thr-24, Ser-256, and Ser-319) that are conserved in other FOXO proteins. We have reported that phosphorylation of Ser-256 is critical for the ability of insulin and insulin-like growth factors to suppress transactivation by FKHR (Guo, S., Rena, G., Cichy, S., He, X., Cohen, P., and Unterman, T. (1999) J. Biol. Chem. 274, 17184 -17192) and for its exclusion from the nucleus (Rena, G., Prescott, A. R., Guo, S., Cohen, P., and Unterman, T. G. Recent studies have revealed that FOXO Forkhead transcription factors are important targets for mediating effects of insulin and growth factors on gene expression downstream from phosphatidylinositol 3-kinase (PI3K) and protein kinase B (PKB; also known as Akt) (1-13). Early findings in this laboratory revealed that Forkhead transcription factors interact with insulin response sequences (IRSs) in the insulin-like growth factor-binding protein-1 (IGFBP-1) and phosphoenolpyruvate carboxykinase (PEPCK) genes (14, 15) and that signaling by PI3K and PKB mediate the ability of insulin to suppress basal IGFBP-1 promoter activity through an IRS (16). Subsequent studies in Caenorhabditis elegans provided genetic evidence that DAF-16, a member of the FOXO subfamily of Forkhead transcription factors, is a major target for signaling by the insulin/IGF receptor-PI3K-PKB pathway in the nematode (17, 18). DAF-16 and its mammalian homologues, including FKHR (FOXO1), FKHRL1 (FOXO3a), and AFX (FOXO4) interact directly with IRSs from the IGFBP-1 promoter in a sequence-specific fashion in in vitro assays and in cells (1, 5, 9, 19, 20) . In liver-derived cells, FOXO proteins stimulate the activity of promoters for IGFBP-1 (1), glucose-6 phosphatase (21, 22), and PEPCK (23, 24) . In other cell types, FOXO proteins also stimulate the expression of proteins that inhibit cell cycle progression, including p27 Kip (25), Rb2 (26), and GADD45 (27, 28) , and proteins that promote cells death, including Bim (29) and Fas ligand (5). Thus, the ability to suppress transactivation by FOXO Forkhead proteins is important for insulin to regulate hepatic production of IGFBP-1 and glucose and for effects of growth factors on cell proliferation and survival.
Recent studies have revealed that FOXO Forkhead transcription factors are important targets for mediating effects of insulin and growth factors on gene expression downstream from phosphatidylinositol 3-kinase (PI3K) and protein kinase B (PKB; also known as Akt) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Early findings in this laboratory revealed that Forkhead transcription factors interact with insulin response sequences (IRSs) in the insulin-like growth factor-binding protein-1 (IGFBP-1) and phosphoenolpyruvate carboxykinase (PEPCK) genes (14, 15) and that signaling by PI3K and PKB mediate the ability of insulin to suppress basal IGFBP-1 promoter activity through an IRS (16) . Subsequent studies in Caenorhabditis elegans provided genetic evidence that DAF-16, a member of the FOXO subfamily of Forkhead transcription factors, is a major target for signaling by the insulin/IGF receptor-PI3K-PKB pathway in the nematode (17, 18) . DAF-16 and its mammalian homologues, including FKHR (FOXO1), FKHRL1 (FOXO3a), and AFX (FOXO4) interact directly with IRSs from the IGFBP-1 promoter in a sequence-specific fashion in in vitro assays and in cells (1, 5, 9, 19, 20) . In liver-derived cells, FOXO proteins stimulate the activity of promoters for IGFBP-1 (1), glucose-6 phosphatase (21, 22) , and PEPCK (23, 24) . In other cell types, FOXO proteins also stimulate the expression of proteins that inhibit cell cycle progression, including p27
Kip (25) , Rb2 (26) , and GADD45 (27, 28) , and proteins that promote cells death, including Bim (29) and Fas ligand (5) . Thus, the ability to suppress transactivation by FOXO Forkhead proteins is important for insulin to regulate hepatic production of IGFBP-1 and glucose and for effects of growth factors on cell proliferation and survival.
Several critical features distinguish FOXO proteins from other Forkhead family members and make them uniquely suited as mediators of insulin and growth factor action. X-ray crystallographic studies with the DBD of HNF-3␥ indicated that the DNA binding motif of Forkhead proteins, named the Forkhead box, or FOX box, contains three ␣-helices, a wing-like structure that spreads out over target sites, and a C-terminal basic region (30) . As shown in Fig. 1 , helix 1 and 2 present helix 3 of the FOX box to the major groove of DNA target sites, where helix 3 interacts directly with the target sequence and mediates sequence-specific binding (30) . FOXO proteins are the most divergent of all Forkhead family members in the region of helix 3, and site-selected PCR amplification studies indicate that FOXO proteins interact preferentially with a consensus target site (GTAAAACAA) that diverges from consensus sequences derived for other Forkhead proteins (31) . This difference in binding specificity provides a basis for directing FOXO proteins preferentially to target sites in insulin-and growth factor-regulated genes.
Crystallographic studies also suggest that the C-terminal basic region of the FOX box may interact as a random coil with phosphate residues in the minor groove of DNA target sites (see Fig. 1 ) and stabilize DNA binding through interactions that are not sequence-specific (30) . However, the role of the basic region in determining binding activity has not been tested directly. Because the Forkhead DBD also contains a nuclear targeting function (32) , and nuclear localization signals are often enriched in basic residues (33) , it has been suggested that this basic region may also function to target FOXO protein to the nucleus, and recent studies in this and other laboratories have supported this possibility (2, 34) . Based on this model, it is reasonable to speculate that changes in the charge of this basic region might impair nuclear targeting and/or DNA binding of FOXO proteins.
Another critical feature that distinguishes FOXO proteins from other Forkhead family members is the presence of three highly conserved phosphorylation sites corresponding to Thr-24, Ser-256, and Ser-319 in human FKHR (3) . The presence of these sites was predicted based on a consensus motif for PKB phosphorylation (Arg-X-Arg-X-X-(Ser/Thr)) (35) and confirmed by 32 P loading studies and studies with phosphospecific antibodies (3, 5, 7, 9, 12) . Although each of these sites can be phosphorylated by PKB in vitro and in cells (3) , recent studies indicate that other PI3K-dependent kinases, such as the serum-and glucocorticoid-inducible protein kinase, may also contribute to the phosphorylation of Thr-24 and/or Ser-319 (6, 11) . Phosphorylation of these sites results in the exclusion of FOXO proteins from the nucleus (2, 5, 12) and is critical for the ability of insulin and growth factors to suppress the function of FOXO proteins (1, 5, 8, 9) . We have reported that phosphorylation of Ser-256 is essential for the ability of insulin and IGFs to suppress transactivation by FKHR and that introducing a negative charge at this site by replacing Ser-256 with an aspartate residue is sufficient to impair IRS-dependent transactivation by FKHR (1). Studies by Rena et al. (2, 3) and Nakae et al. (37) indicate that phosphorylation of Ser-256 may be required for the efficient phosphorylation of Thr-24 and Ser-319, suggesting that Ser-256 may function as a gatekeeper in a process of hierarchical phosphorylation. In this case, phosphorylation of Ser-256 may be critical for regulating the function of FKHR largely because of effects that are mediated through the subsequent phosphorylation of Thr-24 and Ser-319. At the same time, Ser-256 is located at the C-terminal end of the FOX box ( Fig. 1) , suggesting that phosphorylation at this site may be sufficient to alter nuclear targeting of FKHR and/or DNA binding directly, independent of Thr-24/Ser-319 phosphorylation.
To better understand the specific mechanism(s) mediating the effect(s) of phosphorylation on the function of FOXO proteins, we asked whether the phosphorylation of Ser-256 has an effect on transactivation by FKHR that is independent of Thr-24/Ser-319 phosphorylation and whether this effect is mediated through effects on nuclear targeting and/or DNA binding.
Reporter gene studies in 293 cells reveal that Ser-256 phosphorylation can limit transactivation by FKHR through a mechanism that is independent of Thr-24/Ser-319 phosphorylation, whereas cellular trafficking studies indicate that phosphorylation of Thr-24 and/or Ser-319 (but not Ser-256) is critical for nuclear exclusion of FKHR. Gel shift and fluorescence anisotropy studies demonstrate that the introduction of negative charge at the site of Ser-256 is sufficient to limit DNA binding activity. To our knowledge, these studies provide the first direct evidence for a critical role of basic residues in the C-terminal region of the FOX box in DNA binding. Together, they demonstrate that the introduction of a negative charge in this region can limit transactivation by FOXO proteins through multiple mechanisms, including a direct effect on DNA binding.
MATERIALS AND METHODS
Reporter Gene and FKHR Expression Vectors-Oligonucleotides containing an array of three copies of an insulin response sequence (IRSA) in the IGFBP-1 promoter were cloned immediately 5Ј to the 81-bp thymidine kinase promoter and luciferase cDNA in TK⅐IRS3, as reported previously (16) . The FKHR cDNA containing 224 bp of 5Ј-and 133 bp of 3Ј-untranslated sequence was subcloned into the XbaI-AccI site in pAlter.MAX (Promega) downstream from the cytomegalovirus promoter as reported (1) . Single-stranded DNA templates were prepared with helper phage R408 for site-directed mutagenesis using appropriate synthetic oligonucleotides. Mutations were confirmed by dideoxy sequencing in the University of Illinois at Chicago Sequence Center. For studies of cellular trafficking, mutated forms of the FKHR cDNA were cloned in-frame with the GFP cDNA in the BglII-SalI site in pEGFP-N1 ( Clontech).
Cell Culture, Transfection and Reporter Gene Analysis, and Translocation-Human embryonic kidney 293 cells were purchased from the American Type Culture Collection, and 1 ϫ 10 6 cells were plated per 60-mm dish for transfection with calcium phosphate precipitates. Cells were transfected with 10 g plasmid DNA/dish, including 3 g of (30) . As shown, the Forkhead DNA binding motif contains three ␣-helices (H1, H2, and H3). Helix 1 and Helix 2 present H3 for sequence-specific interaction with residues within the major groove of the DNA target site. Wing-like structures (W1 and W2) spread out over the binding region but are not involved directly in DNA/protein binding. The basic region at the C-terminal end of the DNA binding domain may interact as a random coil with phosphate residues in the minor groove. The sequence of the basic region of FKHR is shown. A PKB phosphorylation site (Ser-256; asterisk) located in the basic region is conserved in other members of the FOXO subfamily of Forkhead proteins. This figure is modified from one that was published previously by Lai et al. (36) . It is printed here with permission of the publisher.
TK⅐IRS3, 2 g of a ␤-galactosidase expression vector, with or without 3 g of FKHR expression vectors, and appropriate amounts of empty vector. Transfected cells were re-fed with Dulbecco's modified Eagle's medium plus 1g/liter fatty acid-free bovine serum albumin with or without 100 ng/ml recombinant human IGF-I 18 h prior to the preparation of lysates and analysis of luciferase activity. Experiments were performed in triplicate and repeated at least three times.
For cellular trafficking studies, 293 cells were plated on polysinecoated cover slips and transfected with expression vectors using LipofectAMINE-2000 (Invitrogen) and then stabilized for 18 h in serum-free Dulbecco's modified Eagle's medium prior to treatment with/without 20 nM leptomycin B (Sigma) or LY294002 (Calbiochem). Cells were fixed with 4% parafomaldehyde, and nuclei were stained with 4Ј-6-diamidino-2-phenylindole-2HCl (DAPI; Vector Laboratories). Fusion proteins were visualized by laser confocal microscopy with a Zeiss confocal laser scanning 510 microscope in the University of Illinois at Chicago Research Resource Center.
Recombinant Proteins-Based on initial studies showing that bacterially expressed recombinant proteins containing full-length FKHR are unstable, we prepared proteins containing the DNA binding domain for studies of binding activity. For bacterial expression of recombinant proteins, NdeI and XhoI sites were introduced into the FKHR cDNA by mutagenesis in pAlter.Max, and the fragment of the FKHR cDNA coding for amino acids 160 -266 was cloned in-frame to the C-terminal Leu-Gln-His 6 tag in pET21b (Novagen). The wild-type FKHR DBD and mutant proteins were expressed in BL21-DE3 cells (Stratagene) in LB medium by induction of T7 polymerase at mid-logarithmic growth by addition of 1 mM isopropyl-␤-D-thiogalactopyranoside. Cells were lysed with 8 M urea, and His-tagged proteins were recovered on nickelagarose beads. Proteins were eluted and denatured in 8 M urea, pH 4.5, and renatured by two-step dialysis against phosphate-buffered saline, pH 6.5. Proteins were re-purified by nickel-agarose chromatography, eluted with 8 M urea, pH 4.5, and renatured by dialysis prior to storage in 10% glycerol at Ϫ70°C. Protein concentration was determined by the DC protein assay kit (Bio-Rad). Recombinant proteins were Ͼ95% pure as determined by SDS-PAGE and Coomassie stain.
Circular Dichroism-CD spectra of the wild-type FKHR DBD and mutant proteins were measured with a Jasco 710 circular dichroism spectrometer that was equipped with a ThermoNESLAB circulating water bath that was thermostated to 25 Ϯ 0.1°C. Protein samples were prepared at a concentration of 0.5 mg/ml in phosphate-buffered saline, pH. 7.0, and were placed into a circular quartz cuvette with a pathlength of 0.10 cm. Spectra were recorded over a range of 195-250 ϩ 0.5 nm at 0.5-nm increments with a 1.0-nm bandwidth. The integration time was 1 s, and three measurements were made and averaged at each wavelength at a sensitivity of 50 millidegrees. The secondary structure content was estimated by the method of Deléage et al. (38) using the software program DICROPROT (38) . CD melting curves from 20 to 70°C were measured at 225 nm at 1-degree increments using the same experimental setup.
DNA Binding Studies-Double-stranded oligonucleotide probes containing a naturally occurring FKHR binding site (GCAAAACAA) from the IGFBP-1 promoter (CTAGATGCAAAACA-ACTGTGACTAGTAGA-ACACGG; ⌬IRS.1) or a consensus binding site for FOXO Forkhead proteins (CTAGATGgtAAACAACTGTGACTAGTAGAACACGG; ⌬FOXO) were end-labeled with 32 P. Probes were incubated with 0 to 30 ng of recombinant protein with or without unlabeled competitors for 20 min at 4°C in 20 l of binding buffer (40 mM Tris-HCl, pH 7.5, 5 mM MgCl 2, 0.1 mM EDTA, 1 mM dithiothreitol, 50 mM KCl, 10% glycerol, 0.1% bovine serum albumin, and 50 ng/ml poly(dG-dC)⅐poly(dG-dC)) prior to 10% Tris-glycine polyacrylamide gel electrophoresis at 4°C for 90 min. Gels were dried prior to autoradiography or quantification by phosphorimaging.
Fluorescence anisotropy binding studies were performed on an SLM 8000 spectrofluorometer in T-format with film polarizers. The 5Ј-end of the sense strand of the ⌬IRS.1 probe was tagged with fluorescein during synthesis, and the double-stranded probe was purified on a non-denaturing gel to reduce background. The anisotropy of 10 nM fluorescenttagged probe in 1.2 ml of binding buffer (see above) in an acrylic cuvette (Sarstedt) was measured at 25°C before and after adding 5-1000 nM recombinant protein. Excitation was at 495 nm, and fluorescent emission was detected through a filter that transmitted light at wavelengths Ͼ500 nM (50% transmission at 515 nm). Fluorescence anisotropy (A) was calculated from the ratio of vertically polarized emission (V) to horizontally polarized emission (H) when the sample was excited with vertically polarized light using the equation, A ϭ (V/GH Ϫ 1)/(V/GH ϩ 2), where G is the ratio, V/H, measured with horizontally polarized excitation. The latter ratio corrects for the bias between the two emission channels. Emission intensities were corrected for a buffer blank. The average of three separate readings (10-s integration) taken at each protein concentration was calculated. Binding data were computer fit by nonlinear regression to the quadratic equilibrium binding equation assuming a 1:1 stoichiometry for the protein-DNA probe interaction to obtain the binding dissociation constant (K d ) (39) .
RESULTS
To assess the role of Ser-256 in modulating the function of FKHR, we first performed reporter gene studies in human embryonic kidney 293 cells from ATCC using a luciferase reporter gene construct containing an array of three insulin response sequences upstream of the 81-bp thymidine kinase promoter (TK⅐IRS3). Basal promoter activity of this reporter gene construct is negligible, so that luciferase activity reflects transactivation by FKHR expressed in these cells (2) . As shown in Fig. 2A , IGF-I treatment inhibits transactivation by wild-type FKHR by ϳ50%. Replacing Ser-256 with alanine (S256A) completely disrupts this effect of IGF-I ( Fig. 2A) , indicating that phosphorylation of Ser-256 is critical for the ability of IGF-I to suppress transactivation by FKHR, as reported previously (2) .
Previous studies indicate that Ser-256 phosphorylation precedes (3) and may be required for the phosphorylation of Thr-24 and Ser-319 in FKHR (2, 37). As shown in Fig. 2A , replacing Thr-24 and Ser-319 with alanine (T24A/S319A) partially reduces, but does not completely disrupt, the ability of IGF-I to suppress transactivation by FKHR. This result indicates that Thr-24/Ser-319 phosphorylation contributes to, but does not fully account for, the ability of IGF-I to inhibit transactivation by FKHR. Replacing Ser-256 with alanine, together with Thr-24 and Ser-319 (T24A/S256A/S319A), disrupts the residual effect of IGF-I, indicating that phosphorylation of Ser-256 can contribute to the effect of IGF-I on transactivation by FKHR through a mechanism that does not require Thr-24/Ser-319 phosphorylation.
Studies with phosphospecific antibodies have shown that Thr-24, Ser-256, and Ser-319 are phosphorylated under serum-
FIG. 2. Transactivation by FKHR.
A, effect of IGF-I treatment. 293 cells were co-transfected with a luciferase reporter gene construct (TK⅐IRS3) containing three copies of a naturally occurring FOXO binding site (IRSA from the IGFBP-1 promoter) upstream from the 81-bp minimal thymidine kinase promoter, together with an expression vector for wild-type, T24A/S319A, T24A/S256A/S319A, or T24A/S256D/S319A FKHR. Cells were rinsed and re-fed with Dulbecco's modified Eagle's medium containing 1 mg/ml bovine serum albumin with or without 100 ng/ml IGF-I 18 h prior to lysis and analysis of luciferase activity. For each construct, the effect of IGF-I on transactivation by FKHR is expressed relative to serum-free control. Cumulative results from at least three experiments performed in triplicate are presented as the mean Ϯ S.E. B, transactivation by FKHR. The effect of wild-type, T24A/S319A, T24A/S256A/S319A, or T24A/S256D/S319A FKHR on TK⅐IRS3 promoter activity after 18 h of treatment with serum-free medium is shown. Basal activity of the TK.IRS3 construct is negligible in 293 cells so that luciferase activity reflects transactivation by FKHR. Results are expressed relative to the level of activity obtained in cells transfected with the wild-type FKHR expression vector (100%).
free conditions in 293 cells reflecting basal kinase activity, and IGF-I treatment enhances their phosphorylation (2) . As shown in Fig. 2B , replacing Thr-24 and Ser-319 with alanine (T24A/ S319A) enhances transactivation by FKHR ϳ3-fold compared with WT FKHR in 293 cells that have been stabilized in serumfree medium, indicating that phosphorylation of Thr-24 and Ser-319 limits transactivation by FKHR under basal conditions. Replacing Ser-256 with alanine, together with Thr-24 and Ser-319 (T24A/S256A/S319A), modestly increases transactivation compared with the T24A/S319A mutant, suggesting that phosphorylation at this site may limit basal transactivation by FKHR through a mechanism that is independent of Thr-24/Ser-319 phosphorylation. Conversely, replacing Ser-256 with an aspartate residue (T24A/S256D/S319A) reduces transactivation by two-thirds compared with the T24A/S319A mutant. This result provides direct evidence for the concept that the introduction of a negative charge at this site is sufficient to reduce transactivation by FKHR in the absence of Thr-24/Ser-319 phosphorylation.
We next examined specific mechanisms that may mediate effects of Ser-256 phosphorylation on transactivation by FKHR. Studies in several laboratories have shown that phosphorylation of FKHR results in its exclusion from the nucleus (1, 12, 40) . As shown in the top panel of Fig. 3B , GFP-tagged wild-type FKHR is located largely in the extranuclear compartment of ATCC 293 cells stabilized for 18 h in serum-free medium. Treatment with leptomycin B, which inhibits the function of Crm-1 nuclear export proteins, results in nuclear targeting of FKHR-GFP. These results indicate that FKHR-GFP is actively shuttling in and out of the nucleus and that nuclear targeting of FKHR-GFP is apparent once nuclear export is inhibited. Treatment with LY294002, a PI3K inhibitor that prevents the phosphorylation of Thr-24, Ser-256, and Ser-319 (2, 3), also results in nuclear targeting of FKHR-GFP, as does replacing Thr-24, Ser-256, and Ser-319 with alanine (bottom panel, Fig. 3B ). These studies indicate that PI3K-dependent phosphorylation at these sites is critical for nuclear exclusion of FKHR, consistent with previous studies (1, 12, 40) .
To examine the role of Ser-256 in regulating the distribution of FKHR in 293 cells, we performed studies with additional GFP fusion proteins. As shown in Fig. 3C , replacing Ser-256 with alanine (S256A) results in nuclear targeting of FKHR-GFP, whereas replacing Ser-256 with aspartate (S256D) results in nuclear exclusion. This indicates that phosphorylation and the introduction of a negative charge at this site is critical for nuclear exclusion of FKHR. Because replacing Ser-256 with alanine prevents Thr-24/Ser-319 phosphorylation (2), and replacing Ser-256 with aspartate can partially promote Thr-24/ Ser-319 phosphorylation (2), we asked whether the effect of phosphorylation of Ser-256 on the trafficking of FKHR is because of changes in Thr-24/Ser-319 phosphorylation. Replacing Thr-24 and Ser-319 with alanine results in nuclear targeting of FKHR-GFP, indicating that Thr-24/Ser-319 phosphorylation is critical for nuclear exclusion of FKHR. Replacing Ser-256 with an aspartate residue at the same time (T24A/S256D/S319A) does not disrupt nuclear targeting (bottom panel, Fig. 3C ). These results indicate that the major effect of introducing a negative charge at the site of Ser-256 on nuclear exclusion of FKHR in 293 cells is mediated through Thr-24/Ser-319 phosphorylation.
Studies from this and other laboratories have suggested that basic residues in the C-terminal region of the DNA binding domain may function as a nuclear localization signal (NLS) targeting FOXO proteins to the nucleus (2, 34), and we considered whether introducing a negative charge at the site of Ser-256 may interfere with this function. GFP, which is small enough to pass through nuclear pores by diffusion without an active transport signal, is found in both the nuclear and cytoplasmic compartments when it is expressed in 293 cells (Fig.  4C) . When the basic region of the DBD and flanking residues are expressed in-frame with GFP, the fusion protein is targeted to the nucleus, indicating that this region of the FKHR can function as an NLS, similar to results obtained with the corresponding region of AFX (34) . Replacing Arg-251, Arg-252, and Arg-253 with neutral amino acids disrupts this effect, indicating that these positively charged residues are critical for the function of this NLS (Fig. 4C) . However, replacing Ser-256 with an aspartate residue does not interfere with the ability of this region of FKHR to target the fusion protein to the nucleus (Fig.  4C) . These results, together with the results of studies with full-length fusion proteins (Fig. 3C) , indicate that the introduction of a negative charge at this site is not sufficient to disrupt the function of this NLS or nuclear targeting of FKHR in 293 cells. Together with the results of reporter gene studies (Fig. 2) , these results also indicate that introducing a negative charge at the site of Ser-256 can inhibit transactivation by FKHR through a mechanism that does not require nuclear exclusion.
Based on these observations, we asked whether the phosphorylation of Ser-256 and the introduction of a negative charge in the C-terminal basic region of the FOX box in FKHR may limit DNA binding. Here, we expressed recombinant proteins containing the FKHR DBD with or without mutations in the C-terminal basic region. Proteins were quantified by dye-binding assay, and their purity was assessed by SDS/PAGE and Coomassie stain (Fig. 5A, insert) . As shown in Fig. 5A , 0.1 ng of bacterially expressed protein containing the FKHR DBD is sufficient to bind to a 32 P-labeled double-stranded oligonucleotide probe containing a naturally occurring FKHR binding site (IRSA from the IGFBP-1 promoter), and binding is dosedependent. Studies with unlabeled competitors confirmed that this binding is both competitive and specific (not shown). Replacing Ser-256 with alanine (S256A), a neutral amino acid, does not impair binding. Because the stoichiometry of phosphorylation of this recombinant protein by activated protein kinase B in vitro is limited (Ͻ10%), we examined the effect of introducing a negative charge in this region on binding activity by replacing Ser-256 with an aspartate residue (S256D). As shown, replacing Ser-256 with aspartate reduces DNA binding activity. Also, replacing positively charged arginine residues Arg-251, Arg-252, and Arg-253 in this region with neutral amino acids (RRR/SAS) completely disrupts DNA binding by recombinant proteins. To our knowledge, these results provide the first direct evidence that altering the charge in the C-terminal region of the FOX box motif can impair DNA binding activity in FOXO proteins.
We also considered the possibility that these mutations may impair DNA binding by altering the conformation or stability of the secondary structures within the FOX box motif. Circular dichroism provides a method for estimating the secondary structural content in proteins. As shown in Fig. 5B , the circular dichroism spectrum of the recombinant protein containing the wild-type FKHR DBD is consistent with the presence of significant secondary structure, including ␣-helices, as predicted by crystallographic studies (Fig. 1) . Mutations that replace Ser-256 with aspartate (S256D) or Arg-251-Arg-253 with neutral residues (RRR/SAS) do not significantly alter the circular dichroism spectra of DBD (Fig. 5B) , indicating that the formation of secondary structure in the DBD protein is not impaired by these mutations. CD melting curves of WT, S256D, and RRR/ SAS proteins are also not affected up to a temperature of 70°C (data not shown), indicating that the secondary structures within this region are stable and that mutations in the C-terminal region of the DBD do not impair the stability of these structures. This does not exclude the possibility that small, localized conformational changes may occur upon mutation that might directly alter the binding affinity (41) . However, the primary effect of these mutations on DNA binding ability appears to be disruption of electrostatic interactions (see below).
To further characterize the role of the basic region in DNA binding, we also examined the effects of mutations in this region on the ability of recombinant proteins to bind to a probe where sequence-specific interactions with ␣-helix 3 ( Fig. 1) have been optimized through the introduction of the consensus FOXO binding sequence derived from site-selected PCR amplification studies (31) . Gel shift studies (Fig. 6A ) and analysis by phosphorimaging (Fig. 6B) reveal that replacing Ser-256 with an aspartate residue reduces binding to the probe containing the naturally occurring FKHR binding site (⌬IRS.1) by ϳ50%. Binding of the wild-type DBD is increased ϳ2-fold when a naturally occurring FKHR binding site (GCAAAACAA; ⌬IRS.1) is replaced by the consensus FOXO binding sequence (GTA-AAACAA; ⌬FOXO). The S256D mutation also reduces the ability of the DBD to bind the probe containing a consensus binding site for FOXO proteins but only by ϳ25%. Together, these results indicate that basic residues at the C-terminal end of the FOX box DNA binding motif contribute to binding activity even when sequence-specific interactions with helix 3 are artificially optimized through the introduction of a consensus FOXO binding site. However, the effects of altering the charge in this region are most apparent in the presence of a naturally occurring FKHR binding site, where sequence-specific interactions with helix 3 may not be optimal.
We also performed gel shift studies with recombinant proteins where Arg-251, Arg-252, and Arg-253 were replaced one at a time or where other nearby basic residues (Lys-245 and Lys-248) were replaced with neutral amino acids. Replacing all three arginines (RRR/SAS) or both lysines (KK/AA) completely disrupts the ability of recombinant proteins to bind a naturally occurring FKHR binding site (⌬IRS.1) (Fig. 7A) . Replacing each arginine one at a time partially reduces binding, indicating that each of these residues contributes to binding activity. As shown in Fig. 7B , mutation of these residues also impairs binding to the probe containing the consensus FOXO binding site but not to the same extent. These results indicate that each of the basic residues in this region contribute to DNA binding activity. This result supports the concept that overall charge within this region of the FOX box is important for effective binding, as suggested by crystallographic data (Fig. 1) .
We performed time-course studies to evaluate the kinetics of interactions between the FKHR DBD and its target sites. Initial gel shift studies revealed that binding equilibrium is achieved within 1 min of adding the labeled ⌬IRS.1 probe to wild-type protein at 22°C and that binding is completely reversed within 1 min after adding an excess of unlabelled competitor (not shown). Association and dissociation rates remain high even when binding activity is optimized by performing gel shift studies at 4°C and when the ⌬FOXO probe containing a consensus FOXO binding site is used (not shown). These results indicate that interactions between FOXO proteins and target sites are both rapid and reversible.
To characterize further this interaction and the effects of altering the charge in the C-terminal basic region, we performed fluorescence anisotropy studies with a fluoresceintagged double-stranded oligonucleotide probe containing the naturally occurring DNA binding site (Fl-⌬IRS.1). Initial studies revealed that recombinant protein containing the wild-type FKHR DNA binding domain interacts with this probe in a dose-dependent fashion (Fig. 8) , and studies with untagged competitors confirmed that this interaction is both competitive and specific (not shown). Time-course studies revealed that binding equilibrium between the wild-type DBD and tagged probe is achieved within 10 s, the earliest time point tested. Dissociation also is complete within 10 s after adding the untagged competitor to this complex (not shown), confirming that interactions between the wild-type DBD and target site are rapid and reversible. Dose-response fluorescence anisotropy studies revealed that the wild-type DBD interacts effectively with the fluoresceintagged probe (K d ϭ 93 ϩ 9 nM) (Fig. 8) . Replacing Ser-256 with aspartate results in reduced binding activity (K d ϭ 263 ϩ 24 nM), whereas the RRR/SAS mutation completely disrupts binding in this assay. These results confirm that positive charge within the basic region of the FKHR DBD is critical for effective binding to a naturally occurring FOXO binding site and that the introduction of negative charge at the site of Ser-256 can impair binding to a naturally occurring DNA target site.
DISCUSSION
FOXO Forkhead transcription factors are important targets for insulin and growth factors downstream from PI3K and PKB (see Ref. 13 for a recent review). Three highly conserved phosphorylation sites are present in FKHR (Thr-24, Ser-256, and Ser-319) and other FOXO proteins, and we have reported that the phosphorylation of Ser-256 appears to be particularly important in mediating effects of insulin and IGFs on transactivation by FKHR (1). Phosphorylation of Ser-256 may be required for effective phosphorylation of Thr-24 and Ser-319, based on 32 P-loading studies and studies with phosphospecific antibodies (2, 3, 37) . Here, we examined the role(s) of Ser-256 phosphorylation in mediating the effect of IGF-I and suppressing transactivation by FKHR in 293 cells. Initial studies with reporter gene constructs revealed that phosphorylation of Thr-24 and Ser-319 is required for the full effect of IGF on transactivation by FKHR, consistent with previous studies indicating that these residues contribute to the regulation of the function of FOXO proteins. We found that the phosphorylation of Ser-256 and introduction of a negative charge at this site (by replacing Ser-256 with an aspartate) also inhibits transactivation by FKHR, even when the phosphorylation of Thr-24 and Ser-319 has been prevented by replacing these residues with alanine. This result provides direct evidence that phosphorylation of Ser-256 can limit transactivation by FKHR through a mechanism that is independent of Thr-24 and/or Ser-319 phosphorylation.
Nuclear exclusion is thought to play an important role in limiting the effects of FKHR and other FOXO proteins on gene expression. In the present study, we find that the phosphorylation of Ser-256 is critical for nuclear exclusion of FKHR in 293 cells and that the introduction of a negative charge at this site (by replacing Ser-256 with aspartate) can confer this effect. At the same time, replacing Thr-24 and Ser-319 with alanine results in nuclear targeting of FKHR and disrupts the effect of replacing Ser-256 with aspartate on the trafficking of FKHR. Recent studies suggest that the phosphorylation of Thr-24 and Ser-319 may contribute to the nuclear exclusion of FOXO proteins by enhancing nuclear export (40, 42) . The results of the present study indicate that the phosphorylation of Thr-24 and Ser-319 also is required for the ability of Ser-256 phosphorylation to effectively promote nuclear exclusion of FKHR.
Previous reports have shown that elements within the DNA binding domain are involved in targeting Forkhead proteins to the nucleus (32) . We suggested that residues in the region of the C-terminal end of the DNA binding domain may function as an NLS and reported that replacing several basic residues in this region (Arg-251-Arg-253) impairs nuclear targeting of FKHR (2). Subsequently, Brownawell et al. (34) reported that the basic region of the DBD of AFX, together with basic residues flanking the C-terminal end of the DBD, is sufficient to target GFP to the nucleus in NIH 3T3 (A14) cells and that replacing the residue corresponding to Ser-256 with aspartate partially limits the function of the NLS in this setting. Here we find that the corresponding region in FKHR also is sufficient to target GFP to the nucleus and that mutating basic residues in this region disrupts this function, supporting the concept that this region can function as an NLS. However, we do not detect any effect of replacing Ser-256 with aspartate on the ability of this region in FKHR to target GFP fusion protein to the nucleus in 293 cells. This discrepancy may reflect differences in the cell lines that were used. Also, the fragment we introduced into the NLS-GFP fusion protein is slightly longer than the fragment of AFX that was studied and contains an additional basic residue (Lys-233) that may also contribute to nuclear targeting. Of note, we also find that replacing Ser-256 with aspartate does not impair nuclear targeting of the fusion protein containing full-length FKHR when Thr-24 and Ser-319 are replaced by alanine. This result indicates that the major effect of introducing a negative charge at the site of Ser-256 on the trafficking of full-length FKHR in 293 cells requires the phosphorylation of Thr-24 and/or Ser-319. This does not exclude the possibility that the phosphorylation of Ser-256 may impair the function of this NLS in other settings (34) or that the phosphorylation of Thr-24 and/or Ser-319 may function cooperatively to mask this NLS (19) and inhibit nuclear targeting once FKHR is exported from the nucleus.
Based on x-ray crystallographic studies performed with the DNA binding domain of HNF-3␥, Clark et al. (30) suggested that positively charged basic residues in the C-terminal region of the Forkhead/winged-helix DNA binding motif might interact as a random coil with negatively charged phosphate residues in the minor groove of DNA target sites and stabilize DNA binding. Here, we tested whether basic residues in this region of the FKHR DBD contribute to DNA binding, and we considered whether introducing a negative charge at the site of Ser-256 may alter DNA binding activity. Gel shift and fluorescence anisotropy studies with recombinant proteins reveal that mutations that reduce the positive charge or introduce negative charge into the basic region of the DNA binding domain of FKHR limit its ability to bind to an oligonucleotide probe containing a naturally FOXO binding site. Interestingly, the effect of reducing the positive charge in this region or introducing a negative charge at the site of Ser-256 on binding activity is most apparent when the FKHR DNA binding domain is interacting with a naturally occurring FOXO binding site compared with a consensus sequence. This result indicates that the effect of Ser-256 phosphorylation on the binding to DNA target sites is likely to be most important when FKHR interacts with naturally occurring target sites, where sequence-specific interactions with helix 3 have not been optimized artificially. To our knowledge, these results provide the first direct evidence that positive charge in this region contributes to DNA binding activity and that introducing a negative charge at the site of Ser-256 can impair the binding of a FOXO transcription factor.
We also found that multiple basic residues (Lys-245, Lys-249, Arg-251, Arg-252, and Arg-253) in this region contribute to binding activity. This result supports the concept that overall charge in this region, rather than the formation of a specific structure, is important for effective binding. This finding is consistent with the bimodal model of DNA binding suggested by x-ray crystallography, where helix 3 mediates sequencespecific interactions in the major groove of DNA target sites (e.g. IRSA in the IGFBP-1 promoter), whereas positively charged amino acids in the C-terminal region of the DBD interact with negatively charged phosphate residues in a sequence-independent fashion. Gel shift and fluorescence anisotropy studies indicate that interactions between the FKHR DBD and its target sites are both rapid and reversible. These results suggest that, once in the nucleus, FKHR interacts rapidly and reversibly with its target sites. Previous studies have shown that activated PKB is translocated to the nucleus (44) , and recent reports indicate that FOXO proteins are phosphorylated in the nucleus (34, 40) . As suggested in Fig. 9 , the dissociation of FKHR from its binding sites would provide the opportunity for PKB to phosphorylate Ser-256 in the nucleus. The phosphorylation of Ser-256 would then shift the binding equilibrium of bound and free FKHR, making more unbound FKHR available for phosphorylation at other sites. Also, the phosphorylation of Ser-256 also may result in a conformational change that also may promote the efficient phosphorylation of Thr-24 and Ser-319 (2, 37). Although cell fusion studies with GFP-tagged AFX indicate that phosphorylation is not absolutely required for nuclear FIG. 9 . Effects of Ser-256 phosphorylation on FKHR DNA binding and nuclear/cytoplasmic trafficking. FKHR binds to DNA target sites in the nucleus through sequence-specific interactions mediated through helix 3 and sequence-independent interactions with basic residues in the C-terminal region of the DBD. This binding is rapid and rapidly reversible, reflecting a dynamic equilibrium. In the unbound state, Ser-256 can be phosphorylated by PKB, reducing the binding of FKHR to target sites and increasing the availability of FKHR for phosphorylation at other sites (Thr-24 and Ser-319) by PKB and other kinases, including the serum-and glucocorticoid-inducible kinase (SGK). Phosphorylation of FKHR results in its exclusion from the nucleus.
export of FOXO proteins (34) , recent reports indicate that the phosphorylation of Thr-24 and Ser-319 can enhance nuclear export (40, 42) and, thereby, promote nuclear exclusion (Fig. 9) . Phosphorylation of these sites may also promote nuclear exclusion of FOXO proteins through other mechanisms, e.g. by binding 14 -3-3 proteins that may mask the DNA binding domain (19, 40) and block the function of nuclear targeting sequences once proteins have been exported out of the nucleus.
In summary, the results of the present study indicate that the phosphorylation of Ser-256 at the C-terminal end of the DNA binding domain suppresses the function of FKHR through multiple mechanisms. Positively charged residues in this region make an important contribution to DNA binding, and the introduction of a negative charge at this site can reduce binding activity and limit transactivation by FKHR in the nucleus. The phosphorylation of Ser-256 is also critical for nuclear exclusion of FKHR. However, this effect appears to be mediated largely through the phosphorylation of other sites, including Thr-24 and/or Ser-319.
